勇敢之心生物

最新新闻

• A Quick Look at Today's Ratings for Braveheart Bio(BRVE.US), With a Forecast Between $40 to $48
  \u5e02\u573a\u8d44\u8baf · 2026/9/1
• Stifel Nicolaus Remains a Buy on Braveheart Bio, Inc. (BRVE)
  TipRanks · 2026/10/1
• Analysts Offer Insights on NA Companies: Braveheart Bio, Inc. (BRVE) and TeraWulf Inc (WULF)
  TipRanks · 2026/9/7
• Stifel Maintains Braveheart Bio(BRVE.US) With Buy Rating, Maintains Target Price $45
  \u5e02\u573a\u8d44\u8baf · 2026/10/1
• 评级变动
  Goldman Sachs Remains a Buy on Braveheart Bio, Inc. (BRVE)
  TipRanks · 2026/9/9
• Goldman Sachs Maintains Braveheart Bio(BRVE.US) With Buy Rating, Maintains Target Price $48
  \u5e02\u573a\u8d44\u8baf · 2026/9/9
• 评级变动
  Analysts Offer Insights on NA Companies: IMAX (IMAX) and Braveheart Bio, Inc. (BRVE)
  TipRanks · 2026/9/9

新闻标题为自动聚合内容，未经我们团队独立核实或编辑。